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In Saccharomyces cerevisiae, the major control point in the
cell cycle is the G1-to-S transition known as Start. After passage through Start, cells begin a division program that includes
bud emergence, DNA synthesis, and microtubule-organizing
center duplication (42). Like many cell cycle transitions, passage through Start is controlled by a cyclin-dependent kinase
(Cdc28)–cyclin complex (reviewed in reference 38).
Any one of the three G1 cyclin genes, CLN1, CLN2, or
CLN3, is sufficient for transition through Start (9, 44). However, it is likely that CLN3’s role in Start may be qualitatively
different from the roles of CLN1 and CLN2. This is based on
a variety of observations, including structural homology, regulation of expression, in vivo activities, and in vitro kinase activities (5, 12, 21, 25, 39, 57, 63). From these data, it has been
suggested that the substrates of Cln3 may be different from the
substrates of Cln1 and Cln2 and that the primary function of
Cln3 might be to activate the transcription of other genes,
including CLN1 and CLN2 (57).
After progression through Start, cells are committed to
DNA replication. The mechanistic details by which the Cdc28Cln kinase commits cells to replication are not yet well understood. One likely role for the Cdc28-Cln protein kinase is in
the activation of the transcription factor, MBF (3, 57). MBF
can then induce the transcription of a number of genes required for DNA replication (reviewed in reference 35). The
B-type cyclin genes, CLB5 and CLB6, are expressed at about
the time of Start and promote transit through S phase (17, 51,
57). The Cdc28-Cln kinase may affect Cdc28-Clb5,6 kinase
activity both by activating the transcription of CLB5,6 (57) and
by leading to the degradation of the CLB-specific inhibitor,
p40SIC1 (50).
In addition to having a role as an activator of DNA synthesis
after Start, the Cdc28 kinase is a likely target for the inhibition

of cell cycle progression by proteins involved in checkpoint
pathways. A checkpoint ensures that cells have completed an
early event with sufficient fidelity to proceed to a later event
(24, 59). If an upstream event has not been completed, the cell
cycle must be arrested to allow completion or repair of the
incompletely assembled structure. Both DNA damage and incomplete DNA replication result in checkpoint-mediated cell
cycle arrest (59, 61).
In this work, we describe mutations in RAD27/ERC11/
YKL510, the yeast homolog of the gene encoding FEN-1, a
mammalian structure-specific endonuclease (23). Mutant alleles of rad27/erc11 result in defects associated with DNA
replication and repair. In the absence of both CLN1 and
CLN2, strains with rad27/erc11 point mutations are inviable at
388C and arrest as large-budded cells; expression of CLN1 or
CLN2 suppresses the inviability and Cdc2 arrest in the mutants, apparently without significantly affecting the levels of
DNA damage. CLN1 and CLN2 may either activate another
pathway for DNA synthesis without affecting DNA repair or,
alternatively, override a checkpoint block caused by the DNA
damage found in erc11 mutant strains. Consistent with CLN1
altering regulation of DNA replication, CLN1 overexpression
is lethal in cells defective for MEC1, a DNA damage checkpoint component.
MATERIALS AND METHODS
Strains and media. Media and genetic methods were as described elsewhere
(4, 47). All yeast strains were isogenic with BF264-15D (trp1-1a leu2-3,112 ura3
ade1 his2). Mutant cln1, cln2, and cln3 alleles, CDC28::HA, and the GAL-CLN1
and GAL-CLB5 cassettes have been described previously (10, 11, 16, 44). A
derivative of the LEU2::GAL1::CLN1 cassette in which LEU2 was inactivated
with URA3 was constructed by transforming a leu2::LEU2::GAL1::CLN1 strain
with an HpaI-SalI fragment of pLU23 (9a). pLU23 contains the LEU2 gene
disrupted by introduction of the URA3/KanR cassette from JA53-delP (derived
from JA53, obtained from S. Elledge) into the EcoRV site of LEU2. This
converted leu2::LEU2::GAL1-CLN1 to leu2::URA3::GAL1-CLN1.
Disruption of RAD9 was accomplished by integrating pTW032 (rad9::TRP1)
(60) into strain 1242-8B. Disruption of RAD2 was accomplished by integrating
KM55 (rad2::URA3) (obtained from L. Prakash) into strain 2507-5B. In both
cases, transformants were scored for radiation sensitivity basically as described
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The yeast Saccharomyces cerevisiae has three G1 cyclin (CLN) genes with overlapping functions. To analyze
the functions of the various CLN genes, we examined mutations that result in lethality in conjunction with loss
of cln1 and cln2. We have isolated alleles of RAD27/ERC11/YKL510, the yeast homolog of the gene encoding flap
endonuclease 1, FEN-1. cln1 cln2 rad27/erc11 cells arrest in S phase; this cell cycle arrest is suppressed by the
expression of CLN1 or CLN2 but not by that of CLN3 or the hyperactive CLN3-2. rad27/erc11 mutants are also
defective in DNA damage repair, as determined by their increased sensitivity to a DNA-damaging agent,
increased mitotic recombination rates, and increased spontaneous mutation rates. Unlike the block in cell cycle
progression, these phenotypes are not suppressed by CLN1 or CLN2. CLN1 and CLN2 may activate an
RAD27/ERC11-independent pathway specific for DNA synthesis that CLN3 is incapable of activating. Alternatively, CLN1 and CLN2 may be capable of overriding a checkpoint response which otherwise causes cln1 cln2
rad27/erc11 cells to arrest. These results imply that CLN1 and CLN2 have a role in the regulation of DNA
replication. Consistent with this, GAL-CLN1 expression in checkpoint-deficient, mec1-1 mutant cells results in
both cell death and increased chromosome loss among survivors, suggesting that CLN1 overexpression either
activates defective DNA replication or leads to insensitivity to DNA damage.
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was added to a final concentration of 0.05%, and cells were harvested at 1-h
intervals.
RNA was isolated, probes were labelled, and Northern blots and cell-budding
assays were performed as described elsewhere (36, 39). Quantification of mRNA
levels was performed by using a Molecular Dynamics phosphoimager, and
mRNA loading was normalized by using TCM1 as a loading control.
Immunoprecipitation, immunoblot analysis, and kinase assays. Cultures (100
ml) of yeast cells at 107 cells per ml were harvested by filtration, washed twice in
LSHN buffer (50 mM NaCl, 10 mM HEPES [N-2-hydroxyethylpiperazine-N9-2ethanesulfonic acid] [pH 7.5] per 10% glycerol), and resuspended in LSHNN
buffer (LSHN plus 0.1% Nonidet P-40) with inhibitors (5% aprotinin, 10 mM
NaPPi, 10 mg of leupeptin per ml, 10 mg of pepstatin per ml, 10 mg of phenylmethylsulfonyl fluoride per ml, 1 mM NaVO4, 10 mM NaF, 25 mM b-glycerophosphate). Cells were broken by being vortexed with glass beads (three times
for 2 min each), and the lysate was cleared by spinning the mixture for 2 min at
13,000 3 g. The clarified supernatant was incubated with 1 ml of 12CA5 antibody
(from mouse ascites fluid [Babco]) on ice for 1 h, reclarified by centrifugation,
and then rotated in the presence of protein A beads for 1 h at 48C. Beads were
collected by centrifugation and washed four times with LSHNN buffer and once
with kinase buffer (10 mM HEPES [pH 7.5], 10 mM MgCl2, 1 mM dithiothreitol). After being resuspended in 60 ml of kinase buffer, the sample was split for
kinase assays and Western blot (immunoblot) analysis.
One-quarter of each sample was transferred to a fresh tube for kinase assays.
Kinase mix (1 ml of histone H1 [2 mg/ml], 2 ml of 50 mM ATP, 1 ml of [g32P]ATP
[10 mCi/ml, 3,000 Ci/mmol], 1 ml of H2O) was added, and samples were incubated at 308C for 10 min with occasional mixing. Reactions were terminated by
addition of 23 sample buffer, and mixtures were heated to 958C for 5 min before
being subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis on
a 12% polyacrylamide gel. Protein gels were transferred to Immobilon-P membranes (Millipore) with a semidry-transfer apparatus (Hoefer), and membranes
were exposed to film.
The beads from the remainder of the sample were aspirated dry, 60 ml of 23
sample buffer was added, and samples were treated as described above. Protein
gels were transferred to Immobilon-P membranes with a wet-transfer apparatus
(Hoefer), and proteins were detected by the ECL system (Amersham) according
to the manufacturer’s directions. Primary antibody (rabbit polyclonal anti-HA;
Babco) was used at a dilution of 1:10,000, and secondary antibody was used at a
dilution of 1:1,000.
Mutation rate analysis, mitotic recombination and chromosome loss assays,
and sensitivity to MMS. Rate of mutation to CanR was calculated by the LeaCoulson method of the median (33). Single colonies from YPGal plates were
grown in YPD or YPGal medium. Nine independent cultures of each genotype
were analyzed in the first experiment, and 15 independent cultures of each
genotype were analyzed in the second.
To analyze the amount of chromosome loss and mitotic recombination in
rad27/erc11 mutant strains, ERC11, erc11-2, and erc11::TRP1 diploids
(leu2::LEU2::GAL1-CLN1/leu2::URA3::GAL1-CLN1; note that leu2 and MAT
are on opposite arms of chromosome III) were purified and a single colony was
used to inoculate SCGal-Ura-Leu medium (47). Cultures were grown to early
stationary phase, diluted in YPGal or YPD, and grown for 12 h. Approximately
5 3 106 cells were mixed with an equal number of W3031a or W3031b cells and
mated on filters for 3.5 h as described elsewhere (47). To determine the number
of cells and mating events, cells were sonicated and then plated on SCGal-UraLeu and SCDex-Ura-Leu (to determine input number of viable cells) and mating
events were selected on SCDex-Ade-His. To determine the number of chromosome loss events, the mating selection plates were replica plated to SCDex-AdeHis-Ura and SCDex-Ade-His-Leu. Chromosome loss events were scored as
those which resulted in loss of both MAT and the linked URA3 or LEU2 marker.
For the mec1-1 mutant strains, diploids (MEC1 or mec1-1 and leu2::LEU2::
GAL1-CLN1/leu2::URA3::GAL1-CLN1) were purified and a single colony was
used to inoculate SCDex-Ura-Leu medium. Cultures were grown to early stationary phase and diluted 1:100 in YPRaf and grown for 12 h. These cultures
were then diluted in YPGal or YPD and grown for 12 h. Matings and selections
were performed as described above.
To analyze the sensitivity of strains to MMS, exponential-phase cultures were
grown in YPGal and spread on YPD or YPGal plates. Sterile paper discs
(diameter, 0.635 cm, no. 740-E; Schleicher & Schuell, Keene, N.H.) containing
20 ml of dilutions of MMS (Sigma) were placed on the surface. Plates were
incubated at 308C for 2 days.
Plating efficiency assays. Tenfold serial dilutions in water were made from
fresh stationary-phase cultures, and 5 ml from each dilution was plated. Plates
were incubated for 2 days.

RESULTS
Isolation and characterization of mutant alleles of RAD27/
ERC11/YKL510. To identify potential targets of the Cdc28-Cln
kinase required for cell cycle progression, we have analyzed
mutations that result in lethality in a cln1 cln2 CLN3 background at 388C and are suppressed by expression of CLN1 (see
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elsewhere (60). Other strains containing the rad9 or rad2 disruption were generated by crossing to the original transformants. The mec1-1 allele (62) was
backcrossed five times to BF264-15D strains; multiple strains were examined for
all phenotypes.
The isolation of erc11-1 and erc11-2 has been described previously (5). Because
of a bookkeeping error (4a), strains containing these alleles were incorrectly
reported to have a non-Cdc2 arrest phenotype (5), whereas in fact they had not
been tested. We report here the first characterization of the erc11 arrest; both
erc11 alleles result in first-cycle Cdc2 arrest.
Cloning of RAD27/ERC11/YKL510. Strain 1983-5B (cln1 cln2 CLN3 GAL1CLN1 erc11-2) was transformed with YCp50- and CE101-based genomic libraries (8, 17), and transformants were screened for their ability to grow at 388C on
YPD plates (47). Complementing plasmids were recovered by transformation
into Escherichia coli, analyzed by restriction digestion and Southern blotting, and
mapped by hybridization to a chromoblot and lambda phage grid.
To demonstrate that we had cloned ERC11, plasmid LB46 was digested with
BamHI and used to transform strain 2507-5D (MATa cln1 cln2 CLN3 ura3).
Integration was confirmed by Southern blotting, two independent transformants
were crossed to 2522-23B (MATa cln1 cln2 CLN3 leu2::GAL-CLN1::LEU2 ura3
erc11-2), and tetrads were analyzed.
Plasmid constructions. Plasmid pLB16, recovered from the YCp50-based
genomic library, was digested with BamHI, treated with Klenow fragment, and
religated to form plasmid pLB50.
A 3.8-kb EcoRI fragment from the YCp50-based genomic library plasmid
pLB17 was subcloned into pRS316 (54) to form pLB44. A 4.4-kb EcoRI fragment from LB16 was subcloned into RS316 to form pLB39. pLB17 was digested
with BamHI and religated, which deleted a 3.5-kb fragment and resulted in
LB37. The 3.5-kb BamHI fragment was cloned into pRS316 to form pLB36.
pLB44 was digested with ClaI and religated to form pLB52 and pLB53. In
pLB44, there are two ClaI sites present in the genomic DNA insert, as well as
one site in the vector sequences; pLB53 contains a deletion of all the genomic
DNA to the second ClaI site. pLB52 is most probably the result of a partial digest
and contains a deletion of the genomic DNA to the first ClaI site.
A 2.0-kb BglII fragment from pLB17 was subcloned into pRS306 and pRS316
digested with BamHI, resulting in pLB46 and pLB48. pLB46 was cut with XhoI
and EcoRI, treated with Klenow fragment, and religated to delete the ClaI site
within the polylinker sequences. The resulting plasmid was digested with ClaI
and BamHI to delete a portion of the RAD27/ERC11 coding sequence (from bp
260 to 1756 relative to the ATG start codon), which was replaced by a TRP1/
Kanr cassette from pJA52 (obtained from S. Elledge) to form pLB68.
To disrupt RAD27/ERC11, diploid 2536-2A/2D was transformed with plasmid
pLB68. The occurrence of the transplacement events was confirmed by Southern
blot analysis of the structure of the genomic DNA, and two independently
transformed diploids were sporulated and analyzed.
Sequence analysis. Sequencing of DNAs from plasmids LB37 and LB36 was
performed by using Sequenase version 2.0 according to the manufacturer’s instructions.
Determination of DNA content by fluorescence-activated cell sorter (FACS).
Flow cytometric DNA quantitation was performed as described elsewhere (17).
Pulsed-field gel electrophoresis assay. Yeast strains were grown to early log
phase in YPGal at 30 or 388C. Glucose was added to half of each culture, and
incubation was continued for 6 h. For control samples, hydroxyurea (added
directly; final concentration, 0.1 M) or nocodazole (added from a 10-mg/ml stock
solution in dimethyl sulfoxide; final concentration, 15 mg/ml) was added. The
cdc9 mutant strain, H9C1A1 (obtained from L. Hartwell), was grown to early log
phase at 238C. The culture was split and incubated at 23 or 388C for 6 h.
Chromosomal DNA samples were prepared from strains by a modification of the
method of Schwartz and Cantor (49) as described elsewhere (47), applied to a
1% agarose gel, and electrophoresed in 0.53 TBE (Tris-borate-EDTA) at 15 to
188C for 36 h at 170 V (CHEF-DRII pulsed-field system; Bio-Rad) with an initial
switching time of 70 s ramped to 120 s by a Pulsewave 760 Switcher (Bio-Rad).
Immunofluorescent microscopy. Immunofluorescent staining of yeast cells was
performed by a modification of the methods of Adams and Pringle (1) and
Kilmartin and Adams (30) as described elsewhere (46). Rat monoclonal antiserum against a-tubulin (YOL1/34 [31]) was from Accurate Chemical and Scientific Corp. (Westbury, N.Y.). Secondary antibodies were purchased from
Boehringer Mannheim Biochemicals (Indianapolis, Ind.). The fluorescent DNAspecific dye DAPI (49,6-diamidino-2-phenylindole) was used to visualize yeast
nuclei.
Northern (RNA) analysis. To analyze the cell cycle regulation of ERC11
transcription, RNA was isolated from cells arrested by cdc15-2 block release and
cln block release protocols as described previously (36, 39). CLN2, Pr1, CLB5,
and H2A probes were as described previously (17, 39). A 1.6-kb HindIII-HindIII
fragment was used as an ERC11 probe, and a 0.7-kb NcoI-NcoI fragment was
used as a CDC9 probe. The PCL1 probe was made from pBA674 (the gift of B.
Andrews).
To analyze the induction of ERC11 transcription as a result of DNA damage,
cln1 cln2 CLN3 GAL-CLN1 cells were grown to log phase in media containing
glucose or galactose. To prearrest cells with pheromone before addition of
methyl methane sulfonate (MMS), MATa bar2 cell cultures were preincubated
with a-factor (Sigma) added to a final concentration of 0.1 mM for 2.5 h. MMS
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Fig. 6 and reference 5). These mutations cause an elevated
requirement for CLN function (Erc2) because CLN3 is usually
sufficient to promote transition through the cell cycle. The
screen for erc alleles was performed with a cln1 cln2 CLN3
strain containing GAL-CLN1 on a CEN-based plasmid (5).
The Erc2 phenotype (i.e., viability on galactose and inviability
on glucose) was determined to be due specifically to the presence of the GAL-CLN1 construct by both plasmid loss experiments and backcrossing the putative mutants. Only those mutants which required GAL-CLN1 for their viability on
galactose were retained for further analysis (5), ensuring that
suppression on galactose was due to the expression of CLN1.
Analysis of strains carrying either of the two erc11 alleles
isolated in the screen demonstrated that they are able to grow
on glucose-containing media when they are transformed with
plasmids containing CLN1 or CLN2 under the control of their
endogenous promoters (CEN-based and 2m-based vectors; see
Fig. 6B). Furthermore, we constructed and analyzed strains
containing the erc11-2 allele and an intact chromosomal copy
of either CLN1 or CLN2. It is critical to note that these strains
are able to grow on glucose- or galactose-containing media
(i.e., CLN1 cln2 cln3 erc11 and cln1 CLN2 cln3 erc11 strains are
viable, while cln1 cln2 CLN3 erc11 strains are not). This demonstrates that wild-type levels of CLN1 or CLN2, but not of
CLN3, are sufficient for rescue of the erc11-2 allele. It also
confirms that the rescue of cln1 cln2 CLN3 GAL-CLN1 erc11
strains on galactose as opposed to glucose is not simply due to
the carbon source. Finally, CLN3-2 (an activated allele of
CLN3) and GAL-CLN3 were unable to suppress erc11-2.
Taken together, these data demonstrate that the inviability of
the erc11 mutants on glucose is not simply due to a change in
growth rate, or to an inability to survive on glucose medium,

but rather is due to the specific loss of wild-type levels of the
CLN1 or CLN2 gene product.
Of 28 complementation groups with the Erc2 phenotype,
only those containing erc11 exhibited first-cycle, cell division
cycle (Cdc2) arrest as large-budded cells (55a). cln1 cln2 erc11
mutant cells with GAL-CLN1 arrested with this phenotype and
with first-cycle kinetics when shifted from galactose to glucose
at 388C (Fig. 1 and 2B) or from glucose at 308C to glucose at
388C (data not shown). Furthermore, erc11-2 strains lacking
GAL-CLN1 also displayed these phenotypes when shifted
from galactose at 308C to galactose at 388C (a further control
for carbon source effects; data not shown). cln1 cln2 erc11-2
cells arrested with a single nucleus and short spindle under the
nonpermissive condition (Fig. 1). The cln1 cln2 erc11-2 strains
gradually lost viability at 388C, with only 10% viability after 6
h of incubation. We do not know the explanation for the low
reversibility of the erc11 block.
Arrest with the morphology described above is frequently
associated with a block in DNA replication (6). To determine
if erc11-2 affects DNA synthesis, we examined the DNA content of mutant erc11-2 cells by FACS analysis (Fig. 2). ERC11
strains grown with CLN1 expressed showed a bimodal distribution of DNA content, with peaks at 1 and 2 N (Fig. 2A). The
budding index of the cultures was also consistent with their
distribution throughout the cell cycle (Fig. 2B). Upon repression of CLN1 expression by the addition of glucose, the cln1
cln2 ERC11 strains showed an increase in the number of unbudded, G1 cells as they delayed in their transit through Start
(1 to 2 h after addition of glucose). For the ERC11 cln1 cln2
CLN3 strain, the number of budded cells then increased and
the population redistributed into approximately equal G1 and
G2 populations (by 4 to 5 h after addition of glucose). For the
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FIG. 1. Cdc2 arrest of the erc11-2 mutant. Strains 2507-5B (cln1 cln2 CLN3 GAL-CLN1 ERC11) (A–C) and 1983-5B (cln1 cln2 CLN3 GAL-CLN1 erc11-2) (D–F)
were grown to early log phase in YPGal at 388C, and then glucose was added to repress GAL-CLN1 expression. Six hours after glucose addition, samples were fixed
and cells were examined with Nomarski optics (A and D), by DAPI staining of DNA (B and E), and by indirect immunofluorescent staining of microtubules (C and F).
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ERC11 cln1 cln2 cln3 strain, cells remained unbudded and
accumulated in G1, as expected for a strain devoid of G1 cyclin
function. The increase in fluorescent staining in these cells may
be due to continuing replication of mitochondrial DNA.
When CLN1 was expressed, the erc11-2 mutant cells were
distributed throughout the cell cycle (Fig. 2), although the
profiles of the erc11-2 strains were somewhat different from
that of the wild type. FACS analysis demonstrated that there
were more cells in the S and G2 phases of the cell cycle and the
budding index showed a corresponding increase in the number
of large-budded cells, suggesting a delay in transit through the
S and/or G2 phases of the cell cycle. The difference between
ERC11 and erc11-2 mutant cells was more pronounced with
the erc11-2 cln1 cln2 CLN3 GAL-CLN1 mutant strain than the
erc11-2 cln1 cln2 cln3 GAL-CLN1 strain; the presence of CLN3
may decrease the amount of time spent in the G1 portion of the
cell cycle and lead to accumulation of S/G2 phase cells.
Upon repression of GAL-CLN1 expression by the addition
of glucose, the erc11 strains showed an increase in the number
of unbudded, G1 cells, similar to what was observed with wildtype strains. However, in contrast to wild-type cells, the erc11-2
cln1 cln2 CLN3 cells appeared to pass only slowly through S
phase and failed to redistribute into a discrete G2 peak at 3 to
4 h after repression of CLN1 transcription. This demonstrates
that with repression of CLN1, transit through S phase is
blocked or significantly delayed in the mutant. The increase in
fluorescent staining (possibly due to replication of mitochondrial DNA; see above) makes it difficult to be certain of the
exact nuclear DNA content in these cells at later time points.
However, comparing the erc11-2 cln1 cln2 CLN3 and erc11-2
cln1 cln2 cln3 strains indicates that in the first cycle following
shift to restrictive conditions, erc11-2 cln1 cln2 CLN3 cells

FIG. 3. Chromosomes of erc11-2 and ERC11 strains. Strains 2507-5B (cln1
cln2 CLN3 GAL-CLN1 ERC11) and 1983-5B (cln1 cln2 CLN3 GAL-CLN1
erc11-2) were grown to early log phase in YPGal at 30 and 388C as indicated.
Glucose was added to half of each culture, and incubation was continued for 6
h. Chemical inhibitors (HU, hydroxyurea; Noco, nocodazole) were added to
aliquots of 1983-5B in galactose at 308C. The cdc9 mutant strain, H9C1A1, was
grown at 238C; the culture was split and incubated at 23 or 388C for 6 h.
Chromosomal DNA was isolated from each sample, separated on a pulsed-field
gel, and stained with ethidium bromide. G, galactose; D, dextrose (glucose).

synthesized some DNA but may have been unable to complete
replication. The percentage of budded cells continued to increase in the erc11-2 cln1 cln2 CLN3 culture, and by 6 h after
the shift, about 85% of the cells were arrested with large buds.
To confirm that erc11-2 cells arrested in S phase, we used
pulsed-field gel electrophoresis since chromosomes isolated
from cells arrested in S phase fail to band properly on these
gels (26). Most probably this is due to the presence of replication bubbles, forks, or flaps in the DNA which affect its
migration ability. As expected, DNA isolated from cells
blocked in S phase by a temperature-sensitive DNA ligase
allele (cdc9) or by hydroxyurea treatment failed to band (Fig.
3, 2nd and 11th lanes), while DNA isolated from cells blocked
after DNA replication by the microtubule polymerization inhibitor, nocodazole, demonstrated the characteristic pattern of
chromosome bands (12th lane). Under permissive conditions,
DNA isolated from an erc11-2 mutant strain showed a chromosome-banding pattern similar to that of the parental ERC11
strain (Fig. 3, third through fifth lanes compared with seventh
through ninth lanes). In contrast, under nonpermissive conditions, i.e., in the absence of CLN1 expression at 388C, the DNA
isolated from the erc11-2 mutant fails to band (Fig. 3, sixth
lane). Taken together with the FACS data, this suggests that
the erc11-2 mutant cells arrest in S phase.
Analysis of mutant erc11-1 strains yielded results similar to
those for erc11-2 strains in the pulsed-field gel electrophoresis
assay. Minor alterations in the mobility of specific chromosomes seen for the erc11-2 mutant under permissive conditions
were not observed in the erc11-1 mutant.
Cloning and characterization of YKL510/ERC11: homology
to FEN-1 and RAD2. We cloned the ERC11 gene by complementation of the erc11-2 phenotype. Nineteen plasmids, containing DNA from four different genomic loci, were isolated.
Two loci were identified as CLN1 (three plasmids) and CLN2
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FIG. 2. FACS analysis of the erc11-2 mutant. Strains 1584-4D (cln1 cln2
CLN3 GAL-CLN1 ERC11), 1584-1A (cln1 cln2 cln3 GAL-CLN1 ERC11),
1584-4C (cln1 cln2 CLN3 GAL-CLN1 erc11-2), and 1584-11A (cln1 cln2 cln3
GAL-CLN1 erc11-2) were grown to early log phase in YPGal at 388C, and then
glucose was added at time zero to repress GAL-CLN1 expression. Samples were
fixed, stained with propidium iodide, and counted by using a FACS (A). Aliquots
from each time point were analyzed microscopically to determine the budding
index (B). Small and medium buds are less than two-thirds the size of the
mother, and large buds are at least two-thirds the size of the mother. DEX,
dextrose (glucose). h, unbudded cells; , small or medium buds; ■, large buds.
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(four plasmids). These were expected, because CLN1 and
CLN2, but not CLN3 or CLN3-2 (an activated allele of CLN3),
were able to suppress the erc11-2 defect when present on
CEN-based plasmids (see above). The third locus (11 plasmids) corresponded to RAD27/ERC11/YKL510, while the
fourth (1 plasmid) corresponded to SEL1 (see Discussion).
To identify the ERC11 plasmid, a genomic fragment from
the locus was meiotically mapped by targeted integration of
URA3 followed by tetrad analysis of diploids heterozygous for
the URA3-marked locus and for erc11-2. No recombinant
URA31 erc11-2 spores were generated in 23 tetrads, demonstrating tight linkage between ERC11 and the plasmid DNA.
To confirm that the cloned DNA contained the wild-type
ERC11 gene, we targeted duplicative integration of a plasmid
containing URA3 and DNA from the putative ERC11 locus
into an erc11-2 mutant strain, 1983-5B. Sixteen of 16 transformants were complemented for the Erc2 defect, as evidenced
by their ability to grow at 388C in the absence of CLN1 expression. Subsequently, cells which had removed the duplication by
homologous recombination were selected on 5-fluoro-orotic
acid. Of the 36 colonies tested, 31 were Erc1, demonstrating
that the plasmid contained wild-type ERC11 DNA capable of
repairing the erc11-2 mutation.
We mapped the ERC11 gene to the right arm of chromosome XI, and we identified a BamHI restriction site within the
region required for complementation of the erc11-2 mutation
(Fig. 4). Following bidirectional sequence analysis from this
site, we determined that ERC11 had been sequenced as part of
the chromosome XI sequencing project and had been named
YKL510 (GenBank accession no. S93804 [28]). YKL510 was
later renamed RAD27 on the basis of its homology to RAD2
and the phenotypic analysis of a null allele (43) after our work
had been submitted for publication. In this paper, we refer to
the gene as RAD27/ERC11 to be consistent with our figures
and the mutations that we have characterized as erc11 alleles;
however, we recognize that the RAD27 nomenclature has precedence over the ERC11 designation.
RAD27/ERC11 is highly homologous to the mouse flap endonuclease 1 (FEN-1) gene (60% identical amino acids over
the entire predicted open reading frame) (22, 23), as well as to
Schizosaccharomyces pombe rad21 (56% identical) and a human rad21 homolog (58% identical) (37). The products of
these genes have been implicated biochemically and genetically to have roles in DNA synthesis and repair. They are
members of a larger family which includes Saccharomyces cerevisae RAD2, Schizosaccharomyces pombe rad131, and human
XP-G, which also have roles in DNA repair (7, 20, 48).

FIG. 5. Transcriptional regulation of ERC11 mRNA. (A) cdc15-2 (K2944)
cells were grown at 258C and then arrested in late M phase by shifting the culture
to 368C for 3 h. Synchronous division was induced by shifting cells back to 258C,
and samples for Northern analysis were taken every 12 min. (B) cln1 cln2 CLN3
GAL-CLN1 (2507-5B MATa or 2101-13C MATa bar2) cells were grown in
glucose at 308C. To arrest cells with pheromone before the addition of MMS,
a-factor was added to 2101-13C cells. MMS was added to a final concentration
of 0.05%, and samples were taken at 1-h intervals. Quantification of ERC11
induction was performed by using a Molecular Dynamics phosphoimager, and
mRNA levels were normalized by using TCM1 as a loading control. E, glucose;
F, glucose plus MMS; h, glucose plus pheromone; ■, glucose plus pheromone
plus MMS.

The FEN-1 protein has been demonstrated to have DNA
endonuclease and 59339 exonuclease activity. FEN-1 has also
most likely been purified as a protein, sometimes called MF-1,
required for replication in vitro (18, 27, 56, 58). This factor has
been demonstrated to be required for completion of laggingstrand DNA synthesis. In addition to its activities on DNA, it
has 59339 RNA exonuclease activity on RNA-DNA hybrids
and is likely required for the removal of ribonucleotides at the
59 end of Okazaki fragments.
RAD27/ERC11 transcription is cell cycle regulated and induced by DNA damage. The transcription of many genes involved in DNA synthesis is cell cycle regulated, peaking in late
G1 and being dependent upon promoter elements called MluI
cell cycle boxes (MCB elements) (reviewed in reference 35).
The upstream region of RAD27/ERC11 contains three MluI
sites, as well as three elements with a single base pair change.
The RAD27/ERC11 transcript was cell cycle regulated, peaking
in late G1 similarly to CLN2 (Fig. 5A). The cell cycle regulation of transcription was evident by two different methods of
cell synchronization. In the experiment shown in Fig. 5A, cells
were synchronized by arrest in M phase by incubation of
cdc15-2 mutant cells at the nonpermissive temperature and
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FIG. 4. Localization of ERC11/YKL510. The arrow indicates the extent of
the ERC11/YKL510 open reading frame and predicted direction of transcription.
Lines indicate the genomic DNA present in plasmids, and X indicates a frameshift mutation. Complementation was scored as the ability of a CEN-based
plasmid to complement the temperature-sensitive phenotype of 1983-5B (cln1
cln2 CLN3 GAL-CLN1 erc11-2) on glucose media at 388C. Restriction enzyme
sites are designated as follows: B, BamHI; G, BglII; C, ClaI; R, EcoRI; H,
HindIII.
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released (39). We have also analyzed the transcription of
RAD27/ERC11 after synchronization by arrest of cln1 cln2 cln3
GAL-CLN3 cells in raffinose followed by refeeding with galactose (36) and found similar results (data not shown).
In addition to its being cell cycle regulated, RAD27/ERC11
transcription was induced by a DNA-alkylating agent, MMS.
cln1 cln2 CLN3 GAL-CLN1 strains were treated with MMS.
Steady-state levels of RAD27/ERC11 transcript increased
within 1 h of MMS treatment, and levels showed a 3- to 10-fold
increase at their peak in both glucose and galactose (Fig. 5B
and data not shown). This is similar to the induction we observed for RAD2 (data not shown), a gene previously described
to be induced by DNA damage (45). For two reasons, the
increase in transcript levels is not likely to be due to an accumulation of cells at a point of the cell cycle when the level of
RAD27/ERC11 transcription is high. First, the percentage of
unbudded cells does not change significantly during MMS
treatment, suggesting that cells are not accumulating at any
specific stage of the cell cycle (data not shown). Second, cells
prearrested in the G1 phase of the cell cycle by treatment with
a-factor show a similar increase in RAD27/ERC11 transcription upon treatment with MMS (Fig. 5B). From these experiments, we conclude that RAD27/ERC11 transcription is regulated during cell cycle progression and independently inducible
by DNA damage.
An erc11 null allele causes a severe growth defect which is
partially suppressed by GAL-CLN1. The suppression of
erc11-2 by CLN1 could be due to an increase in RAD27/ERC11
activity or to activation of another pathway that can substitute
for RAD27/ERC11 function. To differentiate between these
possibilities, we constructed a deletion-insertion allele of the
RAD27/ERC11 open reading frame as shown in Fig. 4. Transplacement of erc11::TRP1 into a cln1 cln2 CLN3 GAL-CLN1
diploid strain, followed by sporulation and dissection, allowed
recovery of erc11::TRP1 haploid cells.
Mutant erc11::TRP1 strains displayed a more severe growth
defect than the original erc11-2 mutants did and were not
suppressed to the same extent by overexpression of CLN1 (Fig.
6A). The erc11-2 point mutant shows approximately the same
plating efficiency on galactose as it does on glucose at 308C and
a similar plating efficiency on galactose at 388C. In contrast,
compared with the level on galactose at 308C, the disruption
allele has about a 10-fold decrease in plating efficiency on
glucose at 308C and approximately a 100-fold decrease on
galactose at 388C. Both alleles cause about a 10,000-fold decrease in plating efficiency on glucose at 388C.

The growth of strains containing the erc11::TRP1 allele, as
well as the suppression by GAL-CLN1, was somewhat variable
among different isogenic isolates. Perhaps the growth defect of
the erc11 disruptant strains, coupled with the increased mutation rate caused by erc11 mutations (see below), results in the
accumulation of extragenic suppressor mutations. We compared four erc11::TRP1 GAL-CLN1 strains and four erc11::
TRP1 strains. Strains with GAL-CLN1 demonstrated about a
3- to 11-fold increase in plating efficiency on galactose compared with the efficiency on glucose at 308C and a 10- to
900-fold increase in plating efficiency on galactose compared
with that on glucose at 388C. In contrast, erc11::TRP1 strains
lacking GAL-CLN1 showed only a 1- to 2-fold increase in
plating efficiency on galactose compared with glucose at 308C
and a 1- to 10-fold increase in plating efficiency on galactose
compared with glucose at 388C. These data demonstrate that
suppression of the erc11::TRP1 growth defect by galactose medium is largely due to the presence of the GAL1::CLN1 gene
(although a minor role for galactose as opposed to glucose but
independent of GAL1::CLN1 cannot be excluded).
The arrest morphology of erc11::TRP1 cells is similar to the
phenotype of cells with the point mutation (data not shown),
although the Cdc2 phenotype is slightly less uniform (generally
70 to 80% large-budded cells in erc11::TRP1 arrested strains
compared with 85 to 94% in erc11-2 arrested strains). Furthermore, like the erc11-2 mutation, the null allele also appears to
block completion of S phase, as assayed by pulsed-field gel
electrophoresis (data not shown).
The more extreme phenotype associated with the erc11 null
allele demonstrates that the point mutants isolated in the Erc2
screen do have some residual activity, which may be increased
by CLN1. However, since GAL-CLN1 partially suppresses the
phenotype associated with the disruption allele, the mechanism of suppression may not be due solely to an increase in the
activity of the Erc11 mutant protein.
Analysis of cell-cycle-regulated transcription and Cdc28associated kinase activity in erc11-2 strains. The activity of the
G1 cyclins has been demonstrated to be important for the
transcription of MCB-regulated genes; the Cdc28-Cln kinase
may increase the activity of the MCB-binding protein, MBF
(3). The presence of MCB elements in the RAD27/ERC11
promoter, coupled with the incomplete rescue of the erc11 null
allele by GAL-CLN1, suggested that suppression of erc11-2 by
GAL-CLN1 might be the result of increasing the levels of
RAD27/ERC11 transcription. Therefore, we analyzed RAD27/
ERC11 mRNA levels in the presence and absence of GALCLN1 expression (Fig. 7A). In cln1 cln2 GAL-CLN1 strains
that contained CLN3, the levels of RAD27/ERC11 transcript
decreased transiently when CLN1 expression was repressed,
most likely because of the accumulation of cells in the G1
phase of the cell cycle. Then the levels of RAD27/ERC11
mRNA increased and were similar to the steady-state levels in
the presence of GAL-CLN1 expression. This was true for both
wild-type and erc11-2 strains. However, when strains were devoid of CLN function upon repression of CLN1, RAD27/
ERC11 transcript levels decreased substantially when CLN1
was repressed. Taken together, these data demonstrate that
CLN3 activity is sufficient for the transcriptional activation of
RAD27/ERC11 and make it unlikely that GAL-CLN1 suppresses erc11-2 by transcriptional activation of RAD27/ERC11.
Although GAL-CLN1 does not appear to suppress erc11-2
by a direct effect on the transcription of RAD27/ERC11, GALCLN1 might suppress erc11-2 through an effect on the transcription of other genes. One class of notable candidates are
the B-type cyclins, CLB5 and CLB6. CLB5 and CLB6 appear
to be MCB-regulated genes, and their activity is important for
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FIG. 6. (A) Plating efficiency of erc11 mutant strains. Five-microliter volumes
of 10-fold serial dilutions were made from fresh stationary-phase cultures,
plated, and incubated for 2 days at the indicated temperatures. (B) Suppression
of erc11-2 by high-copy plasmids. Strain 1983-5B (cln1 cln2 CLN3 GAL-CLN1
erc11-2) was transformed with 2mm-based plasmids with the indicated genomic
DNA inserts. Single colonies from four transformants of each genotype were
inoculated onto plates by using a 48-prong inoculator and incubated for 2 days.
DEX, dextrose (glucose); GAL, galactose.
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transit through S phase (17, 51). To address whether GALCLN1 suppresses erc11-2 through activation of MCB-regulated
genes, in particular, CLB5 and CLB6, we have analyzed the
ability of CLB5 to suppress erc11-2, as well as the transcript
levels of CLB5 and the activity of the Cdc28 kinase.
When we compared the suppression of erc11-2 by GALCLB5 with that by GAL-CLN1, we found that erc11-2 strains
with GAL-CLB5 had a 10-fold decrease in plating efficiency
and much smaller colonies than erc11-2 GAL-CLN1 strains
(data not shown). erc11-2 strains with both GAL-CLN1 and
GAL-CLB5 resembled GAL-CLN1 strains, demonstrating that
GAL-CLB5 is not toxic to erc11-2 mutant cells. Given the weak
suppression of erc11-2 by GAL-CLB5 (this plasmid construct
results in strong overexpression of CLB5 [data not shown]), it
is unlikely that the suppression of erc11-2 by GAL-CLN1 is
entirely mediated through CLB5.
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We analyzed both the transcript levels of CLB5 and the
activity of the Cdc28 kinase in cln1 cln2 CLN3 strains that
contained ERC11 or erc11-2, in the presence and absence of
GAL-CLN1 expression. Similar to the situation with ERC11
mRNA, levels of the CLB5 transcript transiently decreased
upon repression of GAL-CLN1 in cln1 cln2 CLN3 strains and
then increased to levels comparable to those present before
CLN1 repression (Fig. 7A). The ERC11 and erc11-2 strains
behaved comparably to one another. In cln1 cln2 cln3 GALCLN1 strains, the level of CLB5 mRNA decreased more dramatically and remained lower than in the cln1 cln2 CLN3
GAL-CLN1 strains for about 4 h after CLN1 repression. For
unknown reasons, CLB5 transcript levels increased at later
times after CLN1 repression. This experiment demonstrates
that in cln1 cln2 CLN3 cells, CLN3 is capable of activating
CLB5 transcription to a level similar to the level found when
GAL-CLN1 expression is present, in both ERC11 and erc11-2
strains. Therefore, the inefficient replication of cln1 cln2 CLN3
erc11-2 strains is not due to a deficit in CLB5 expression. The
transcription levels of CDC9, another MCB-regulated gene,
were also comparable in the ERC11 and erc11-2 strains in the
presence and absence of GAL-CLN1 expression (Fig. 7A).
When we examined the levels of the H2A transcript, which is
not MCB regulated (41), we observed a slight reduction in
response to turning off GAL-CLN1. This difference was more
pronounced in the ERC11 strain than in the erc11-2 strain. We
do not yet know the significance of this difference; CLN1 may
have a direct effect on the levels of histone transcription, or this
may be the result of a difference in the cell cycle distributions
between these strains.
Finally, we also examined the transcription of an SCB-regulated transcript, PCL1 (HCS26) (40, 57). The regulation of
the levels of the PCL1 transcript was similar to that of CLB5
and was comparable in the ERC11 and erc11-2 strains, in both
the presence and absence of GAL-CLN1 expression (data not
shown).
Overall, these measurements of transcript levels indicate
that in either erc11-2 or ERC11 strains, the presence of CLN3
is entirely sufficient for activating transcription of both SCBand MCB-regulated genes. CLN3 is required for this activation, at least for several hours following inactivation of GALCLN1 (Fig. 7A). Therefore, it is unlikely that rescue of erc11-2
inviability by CLN1 is due to differential activation of transcription by CLN1 as opposed to CLN3.
Although transcriptional levels of CLB5 are similar in
ERC11 and erc11-2 strains in both the presence and absence of
CLN1 expression, posttranscriptional effects on the activity of
the Cdc28-cyclin kinase could account for the cell cycle arrest
of erc11 strains. For example, the inactivation of p40SIC1, the
Cdc28-Clb kinase-specific inhibitor, requires Cdc28-Cln kinase
function. We analyzed the levels of Cdc28-associated kinase
activity in ERC11 and erc11-2 strains (Fig. 7B). Because the
Cdc28-Clb kinase activity is much greater than the Cdc28-Cln
kinase activity (19), most of the kinase activity detected in this
assay can be attributed to the Cdc28-Clb kinase.
In the erc11-2 strains grown in the presence of CLN1 expression, there was a high level of Cdc28-associated kinase
activity compared with the level in ERC11 control strains. This
is probably due at least in part to the increase in the number of
cells in the S and G2 phases of the cell cycle (Fig. 2), when the
level of Cdc28-Clb kinase activity is high. After repression of
CLN1, the levels of kinase activity in both the ERC11 CLN3
and erc11-2 CLN3 strains were similar to the levels present
before inactivation of CLN1. In the cln3 strains, which contained no G1 cyclin activity upon repression of CLN1, the
levels of Cdc28-associated kinase activity decreased when
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FIG. 7. Strains 1584-4D (cln1 cln2 CLN3 GAL-CLN1 ERC11 CDC28::HA),
1584-1A (cln1 cln2 cln3 GAL-CLN1 ERC11 CDC28::HA), 1584-4C (cln1 cln2
CLN3 GAL-CLN1 erc11-2 CDC28::HA), and 1584-11A (cln1 cln2 cln3 GALCLN1 erc11-2 CDC28::HA) were grown to early log phase in YPGal at 388C, and
then glucose was added at time zero, to repress GAL-CLN1 expression. (A)
Transcriptional regulation in erc11-2 mutant cells. Samples were taken at 30-min
intervals. Probes were as indicated, quantification was performed with a Molecular Dynamics phosphoimager, and mRNA levels were normalized by using
TCM1 as a loading control. DEX, dextrose (glucose). (B) Cdc28-associated
kinase activity in erc11-2 mutant strains. Early-log-phase cultures in YPGal at
388C were split, glucose was added to half, and incubation continued for 4 h.
Cdc28::HA was immunoprecipitated under native conditions from cell extracts
made from the indicated strains. A fraction of the immunoprecipitation was
Western blotted to analyze Cdc28 levels. The remainder was used for a kinase
assay with histone H1 as a substrate to assay Cdc28-associated kinase activity.
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TABLE 1. Spontaneous mutation rates in erc11 mutant cells
Rate of CanR eventsa (1028)
Genotype
GAL

DEX

ERC11
erc11-2
erc11::TRP1

0.68
21
99

2.7
40
12

ERC11
erc11::TRP1

1.1
62

2.4
64

CLN1 was repressed. Although the Cdc28-associated kinase
activity assayed is not due directly to Cdc28-Cln kinase, G1
cyclin activity is required for both CLB transcription and inactivation of p40SIC1. Taken together with the transcriptional
activation of CLB5, these data demonstrate that CLN3 activity
in erc11-2 mutant cells is sufficient for the activation of Cdc28associated kinase, making it unlikely that the block to cell cycle
progression is due to a general failure to activate CLB-dependent kinase activity in the erc11 mutant. We do not know the
contribution of specific Clb proteins to the bulk Cdc28-associated kinase we have measured. However, the results of Schwob
et al. (50) indicate that the six CLB genes are redundant for
activation of DNA replication.
ERC11 is important for repair of DNA damage. Many genes
involved in DNA replication also have a role in DNA repair.
Furthermore, like defects in DNA synthesis, defects in DNA
repair might also lead to cell cycle arrest, due to DNA damage
checkpoints. Therefore, we analyzed erc11-2 and erc11::TRP1
strains for phenotypes associated with the repair of DNA damage. Although erc11 mutants are not UV sensitive (see below),
they do display phenotypes associated with a defect in DNA
repair. Surprisingly, CLN1 expression does not suppress any of
these erc11 defects.
We analyzed the spontaneous mutation rate in wild-type and
mutant cells by assaying the frequency of canavanine-resistant
cells (Table 1). Cells containing either the erc11-2 or
erc11::TRP1 allele mutated to CanR at a higher frequency than
did wild-type cells.
Mutant erc11 strains are about 10-fold more sensitive than
wild-type cells to the DNA-damaging agent MMS, as indicated
by a halo assay (Fig. 8A).
Mutations in erc11 cause a striking increase in the recombination rate. Both erc11-2 and erc11::TRP1 cause an approximately 100-fold increase in the loss of heterozygosity at the
MAT locus, as determined by the increase in mating proficiency of diploid cells. This increase is due almost exclusively to
recombination, as most events resulting in mating competency
were associated with the retention of a marker on the opposite
side of the centromere from the MAT locus, as would be
expected for recombination (but not for chromosome loss)
(Fig. 8B).
We also assayed for DNA damage more directly by testing
for the presence of nicks. We analyzed the amount of radioactive nucleotide incorporated by Klenow enzyme into DNA
isolated from erc11 mutant and wild-type strains as well as the
size of the radiolabelled DNA fragments. Analysis of the radiolabelled products by denaturing alkaline agarose gel electrophoresis demonstrated that DNA isolated from both
erc11-2 and erc11 null mutant strains had incorporated more

FIG. 8. (A) Sensitivity of strains to the DNA-damaging agent MMS. Exponential-phase cultures were grown in YPGal, and an aliquot (0.2 ml) was spread
on YPD or YPGal plates. Filter paper discs containing 20 ml of MMS at 5%
(upper left spot), 1.5% (upper right), 0.5% (lower left), and 0.15% (lower right)
were placed on the surface. Plates were incubated at 308C for 2 days. Panels: i,
2507-5B; ii, 1983-5B; iii, 2562-5A. (B) Recombination and chromosome loss
levels in erc11 mutant strains. A quantitative mating assay was used to score for
the loss of heterozygosity at the MAT locus in diploids. Chromosome loss events
are those which result in loss of both MAT and a linked marker; recombination
events result in loss of heterozygosity at MAT and retention of a linked marker
on the opposite side of the centromere. Data shown are from the MATa cross;
similar results were found with crosses to a MATa tester. DEX, dextrose (glucose); GAL, galactose; recomb, recombination.

label and was on average, smaller than DNA isolated from
wild-type strains (data not shown). This effect was largely independent of CLN1 expression, consistent with the observations above suggesting that erc11 causes defects in DNA synthesis and/or repair that are not suppressed by CLN1.
ERC11 and RAD2 have distinct roles in vivo. RAD27/ERC11
and RAD2 are members of the same gene family by sequence.
To test for genetic interactions and functional similarities between them, we transplaced rad2 null mutations into cln1 cln2
CLN3 GAL-CLN1 strains. These null mutations did not result
in an Erc2 phenotype. We crossed erc11::TRP1 and rad2::
URA3 haploids and examined the meiotic progeny. Spores
containing both mutations were recovered at the expected frequency for unlinked genes. The erc11::TRP1 and erc11::TRP1
rad2::URA3 mutants displayed similar plating efficiencies on
glucose and galactose at 30 and 388C. erc11::TRP1 mutants are
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a
Cells were plated on YPGal and SCGal lacking Arg and containing canavanine to determine viable and CanR cells. Rates were calculated by the LeaCoulson method of the median (33) from the analysis of 9 independent cultures
for each carbon source for the first experiment and 15 independent cultures for
each carbon source for the second experiment. GAL, galactose; DEX, dextrose
(glucose).
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DISCUSSION
We describe the isolation and characterization of mutations
in RAD27/ERC11/YKL510. Mutations in erc11 result in cell
cycle arrest of cln1 cln2 CLN3 strains, a phenotype that is
suppressed by expression of CLN1 or CLN2. Characterization
of the erc11 arrest demonstrates that cells are blocked in the
completion of DNA synthesis. First, cells arrest with a large
bud, a short spindle, and a single nucleus. This phenotype is
identical to that associated with other mutations that affect
DNA replication. Second, FACS analysis demonstrates that
cells are crippled in their capability to synthesize DNA, as their
progression is greatly delayed compared with that of wild-type
cells, and they may not actually complete synthesis. Finally,
DNA isolated from erc11 mutants is unable to band on CHEF

FIG. 9. (A) Inviability of mec1-1 GAL-CLN1 strains. Spores from a diploid
strain heterozygous for mec1-1 and GAL-CLN1 were inoculated onto glucose
and galactose media and grown for 2 days. The mec1-1 genotype was assigned to
spores on the basis of complementation testing with known mec1-1 mutant
strains for hydroxyurea sensitivity. The GAL-CLN1 genotype was assigned on the
basis of Leu1 prototrophy; the integrated construct is a LEU2::GAL1::CLN1
cassette. Dex, dextrose (glucose); Gal, galactose. (B) Recombination and chromosome loss levels in MEC1 and mec1-1 mutant strains. A quantitative mating
assay was used to score for the loss of heterozygosity at the MAT locus in diploids
after 12 h of growth in galactose or glucose. Chromosome loss events are those
which result in loss of both MAT and a linked marker; recombination events
result in loss of heterozygosity at MAT and retention of a linked marker on the
opposite side of the centromere. Data shown are from the MATa cross; similar
results were found with crosses to a MATa tester. DEX, dextrose (glucose);
GAL, galactose; recomb, recombination.

gels, as has been described for mutations and conditions with
which cell growth is arrested in S phase.
Mutations in erc11 also cause defects in DNA repair, including an increased spontaneous mutation rate, increased sensitivity to a DNA-damaging agent, and increased recombination.
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not UV sensitive, and the rad2::URA3 and erc11::TRP1 rad2::
URA3 mutants displayed similar sensitivities to UV irradiation
(data not shown). These results suggest that although Rad2
and Erc11/Rad27 share significant homology, they may have
little functional overlap in vivo.
CLN1, erc11, and cell cycle checkpoints. Many mutations
that block DNA replication cause a Cdc2 cell cycle arrest due
to checkpoint control: the failure to complete replication activates a regulatory process blocking cell cycle progression (24,
59). The RAD9 and MEC1 genes encode components of this
checkpoint pathway (59, 62). To test if the Cdc2 arrest of erc11
cln1 cln2 strains was due to a checkpoint control assaying the
completion of DNA replication, we wanted to construct erc11
rad9 and erc11 mec1 strains. GAL-CLN1 rad9 erc11-2 strains
were inviable on both galactose and glucose at 388C (data not
shown). The cln1 cln2 rad9 erc11-2 mutants failed to arrest with
a Cdc2 phenotype in either the presence or absence of CLN1
expression, demonstrating that the arrest morphology of cln1
cln2 erc11-2 mutant cells is dependent upon RAD9. Because
the cln1 cln2 rad9 erc11-2 mutants now fail to show Cdc2
arrest, we conclude that Cdc2 arrest in the absence of Cln1 is
caused by a checkpoint mechanism assaying the completion of
DNA replication. The inviability of erc11-2 rad9 mutants suggests that GAL-CLN1 is dependent upon a RAD9 checkpoint
for suppression of the erc11-2 defect. The requirement for
RAD9 is also consistent with the high level of Cdc28-associated
kinase activity in the erc11-2 strains; the RAD9-dependent
G2/M checkpoint arrest or pause is associated with high levels
of Cdc28-associated kinase activity (55).
We were unable to analyze the effect of the mec1-1 mutation
on erc11 mutants, because mec1-1 ERC11 GAL-CLN1 cells
demonstrated a severe growth defect on galactose in comparison with mec1-1 cells without GAL-CLN1 (Fig. 9A). On galactose, mec1-1 ERC11 GAL-CLN1 cells continued cell division, which led to an increase in cell number; however, inviable
cells accumulated in the population. After 12 h of growth in
galactose, approximately 90% of the cells in the culture were
unable to form colonies when plated.
To analyze this effect of GAL-CLN1, we monitored chromosome loss and recombination events in diploids by assaying
for the formation of mating cells (Fig. 9B). mec1-1 caused
about a 10-fold increase in loss and recombination, even in the
absence of GAL1::CLN1 expression, from the levels obtained
with MEC1 strains. A 12-h pulse of galactose to activate
GAL1::CLN1 transcription resulted in a 100-fold increase in
loss and recombination compared with levels for MEC1 controls. Therefore, the inviability caused by GAL-CLN1 expression may be due to effects on DNA synthesis or chromosome
segregation.
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promote cell cycle progression in a way qualitatively different
from that of CLN3 (see the introduction).
Previously identified roles for the G1 cyclins in control of
DNA synthesis include the activation of transcription of genes
required for S phase, including the CLB genes, as well as the
activation of Cdc28-Clb kinases, probably by inhibition of
p40SIC1 (50, 57). CLN3 appears to be at least as potent an
activator of transcription as CLN1 (57; also see above), making
it unlikely that CLN1 and CLN2 suppress erc11 by activating
the general transcription of genes required for DNA synthesis.
In particular, we have tested cln1 cln2 strains (both erc11-2 and
ERC11) for induction of RAD27/ERC11 itself, as well as the
MCB-controlled genes CDC9 and CLB5 and the SCB-controlled gene PCL1, and have observed no defect in their induction in the absence of CLN1 expression. At most, a modest
defect in histone H2A transcription as a result of turning off
CLN1 expression was observed. Therefore, we consider it unlikely that the defect in cln1 cln2 erc11-2 strains that is suppressed by CLN1 or CLN2 expression is due to defects in
transcriptional induction of other genes. However, it remains
possible that CLN1 and CLN2 do suppress erc11 via the activation of the transcription of genes not yet identified.
In addition to being proficient in activating transcription of
SCB- and MCB-regulated genes, cln1 cln2 erc11-2 strains contained high levels of Cdc28p-associated histone H1 kinase activity, suggesting that the Sic1p inhibitor of Cdc28-Clb kinase
activity was not functioning. These results suggest a direct role
for CLN1 and CLN2 in regulation of DNA replication independent of activating Clb protein expression and kinase activity (50).
We have identified two possible components of the hypothetical CLN1- or CLN2-dependent pathway, SEL1 (suppressor of erc11, encoding a potential helicase) and CDC9 (encoding DNA ligase). Increased levels of these proteins can
suppress the erc11-2 DNA synthesis defect (57b). Furthermore, deletion of SEL1 and ERC11 is synthetically lethal, even
in the presence of CLN1, as would be predicted for the disruption of a component in each of two functionally redundant
pathways. Finally, like CLN1 and CLN2, SEL1 and CDC9 can
suppress the temperature-sensitive lethality of erc11-2 but are
unable to suppress the MMS-sensitive erc11-2 phenotype (associated with defects in DNA repair).
The observation that CLN1 and CLN2 are unable to complement the requirement for RAD27/ERC11 in DNA repair
could cast doubt on the idea that CLN1 and CLN2 may activate a parallel pathway that can at least partially bypass the
requirement for RAD27/ERC11 function in replicative DNA
synthesis. Ad hoc explanations to accommodate this fact could
include the following: CLN1 and CLN2 can interact with Erc11
at only a subset of the temporal or spatial domains at which
Erc11 functions; RAD27/ERC11 has two different activities in
vivo, loss of only one of which (required for DNA synthesis)
can be suppressed by an alternative pathway activated by
CLN1 and CLN2; and a function activated by CLN1 and CLN2
is present at the time appropriate for its having a role in DNA
synthesis but is not expressed at a time appropriate for its
having a role in DNA damage repair. However, we lack direct
evidence in favor of any of these explanations. An alternative
explanation is presented below.
Possible mechanism of suppression of erc11 by CLN1: bypass of a checkpoint arrest. Although CLN1 and CLN2 suppress the inviability and cell cycle arrest caused by erc11-1 and
erc11-2 in cln1 cln2 CLN3 cells, they are apparently unable to
suppress any other erc11 phenotypes. One interpretation of
this surprising result is that cln1 cln2 CLN3 cells arrest because
of the defects caused by the erc11 alleles and that CLN1 allows
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Although CLN1 expression suppresses the block in replication
caused by erc11-2, it fails to suppress any of the defects associated with DNA damage.
The phenotypes associated with erc11 alleles, as well as the
cell-cycle-regulated and damage-inducible transcription of
RAD27/ERC11, are in vivo evidence for functions for the protein in both DNA replication and repair. A role in these functions was suggested by the in vitro biochemical activity described for Rad27/Erc11/Ykl510, and its mammalian homolog,
FEN-1, as a DNA flap endonuclease (22, 23). It was postulated
that FEN-1 activity might be required during DNA repair to
cleave a damaged strand of DNA after unwinding and during
lagging-strand DNA synthesis for cleavage and ligation of displaced Okazaki fragments. After this manuscript was submitted, Reagan et al. published an article characterizing the phenotypes associated with disruption of Rad27/Erc11/Ykl510 in
CLN1 CLN2 CLN3 cells (43). They found that disruption of
RAD27/ERC11 caused temperature-sensitive cell inviability
with defects associated with a block in the completion of DNA
replication. Their analysis and conclusions are consistent with
the data presented here demonstrating that RAD27/ERC11 has
critical roles in both DNA replication and repair.
Isolation of erc11/ykl510 in a screen for mutations that require increased G1 cyclin dosage. The isolation of mutant
alleles of RAD27/ERC11 synthetically lethal with cln1 cln2
defines a link between Start and DNA replication and/or repair. One interpretation of the isolation of rad27/erc11 in this
context is that either the fidelity or the rate of DNA replication
is broadly compromised in cln1 cln2 cells and, therefore, that a
number of mutations in the DNA replication or repair pathway
could cause synthetic lethality with cln1 cln2 (an Erc2 phenotype). For a number of reasons, we do not favor this hypothesis. First, we have been unable to observe any differences
between cln1 cln2 CLN3 cells and cln1 cln2 CLN3 GAL-CLN1
cells in sensitivity to MMS, hydroxyurea, or UV irradiation
(55a, 57a). Second, the numbers of cells in S phase, as assayed
by FACS, are not strikingly different for the two genotypes,
suggesting that this is not a kinetic slow point in cln1 cln2
CLN3 cells. Third, deletion of rad2, a gene known to be required for some types of DNA repair, does not cause the Erc2
phenotype. Fourth, many genes required for DNA replication
have been identified; mutations in most cause Cdc2 arrest.
RAD27/ERC11 is the only complementation group identified
in our screen thus far which results in the budded-cell arrest
phenotype characteristic of mutants defective in DNA synthesis. Taking these data together, it appears that if cln1 cln2 cells
do make defective DNA, the defects are subtle, specific, and
not synergistic with those associated with other DNA-damaging agents; if synthesis is indeed defective, Erc11 and only a
few other proteins may be specifically required to repair the
defects generated in cln1 cln2 cells.
One possible mechanism of suppression of erc11 by CLN1:
activation of Erc11 and/or another pathway. Mutant erc11
alleles result in lethality in cln1 cln2 CLN3 cells. The phenotype of these cells demonstrates that in the absence of CLN1
and CLN2, cells are dependent upon RAD27/ERC11 for progression through S phase. One interpretation is that CLN1 and
CLN2 can activate another pathway for DNA replication that
is at least partially RAD27/ERC11 independent, while CLN3 is
unable to activate this pathway. This does not necessarily imply
that RAD27/ERC11 is a substrate of the Cdc28-Cln kinase,
only that in the absence of CLN1 and CLN2, cells are dependent upon a pathway within which RAD27/ERC11 is an essential component. The ability of CLN1 and CLN2 to activate a
DNA synthesis pathway that CLN3 is unable to activate is
consistent with a variety of observations that CLN1 and CLN2
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the cells to progress through the cell cycle by ignoring these
defects, not by repairing them. It may be that the erc11 damage
results in a response which inhibits Cdc28-Cln3 kinase but fails
to inhibit Cdc28-Cln1 kinase. This differential inhibition may
be the result of quantitative or qualitative differences between
the Cdc28-Cln kinases.
If CLN1 and CLN2 function causes the bypass of a checkpoint-mediated arrest, the levels of DNA damage or disrepair
generated by reducing erc11 function must not be lethal. Otherwise, bypass of the checkpoint would result in cell death.
Apparently the levels of damage caused by erc11 are sublethal
only when RAD9 is functional. The requirement for RAD9 is
consistent with the presence of DNA damage and demonstrates that some checkpoint response is, in fact, required for
suppression. Perhaps CLN1 causes a bypass of one checkpoint
in erc11 mutant cells, allowing replicative DNA synthesis, but
that then a pause at another checkpoint (RAD9 dependent) is
required to allow successful completion of DNA synthesis or
some repair before mitosis.
It is also interesting in this context that CLN1 overexpression is lethal in cells defective for the MEC1-dependent DNA
damage checkpoint (Fig. 9). Perhaps mec1-1 strains are dependent for viability on the same checkpoint bypassed by CLN1 in
the erc11-2 background. This idea could lead to the prediction
that mec1-1 might be synthetically lethal with rad9; however,
this appears not to be the case (unpublished results). Alternatively, CLN1 overexpression could somehow activate defective
or error-prone DNA replication, requiring a pause at a MEC1dependent checkpoint for repair.
Previous work has indicated that some checkpoints do function through the inhibition of cyclin-dependent kinases and cyclins. In Schizosaccharomyces pombe, inhibitory phosphorylation
of cdc2p, the Cdc28p homolog, is required for hydroxyureainduced cell cycle arrest; in the absence of phosphorylation,
cells experience mitotic catastrophe (15, 34). Furthermore, in
mammalian cells, DNA damage in G1 causes cell cycle arrest
and decreased CDK activity. This effect is p53 dependent (29,
32) and is due, at least in part, to inhibition of the activity of
cyclin E-cdk2 complexes by the p53-inducible p21WAF/CIP1 protein and reduction of the levels of cyclins A and D1 (13, 14).
It has recently been demonstrated that in Saccharomyces
cerevisiae, RAD9, previously shown to be required for arrest in
G2/M, is also required for arrest in the G1/S phase after UV
irradiation (52, 53). Perhaps RAD9 affects both Cdc28-Cln and
Cdc28-Clb kinase activity. Although RAD9-mediated arrest is
characterized by high kinase levels at the G2/M checkpoint
(55), the size of complexes containing Cdc28-cyclin from
checkpoint-arrested cells is different from that of complexes
from nonarrested cells. This demonstrates that there is some
effect on the Cdc28-cyclin complex. Another possible connection between the Cdc28 kinase and checkpoints is that a lossof-function mutation in CKS1, a Cdc28-cyclin binding protein
and the budding yeast homolog of p13suc1, can suppress a
mutation in the checkpoint gene RAD53 (MEC2/SAD1) (2).
Rad53p may inhibit Cdc28 kinase activity or alter kinase specificity by affecting CKS1 function. Our observations that GALCLN1 dramatically affects the viability of mec1-1 strains may
reveal an additional link between checkpoints and cyclin-dependent kinases. High, constitutive levels of CLN1 may either
cause insensitivity to DNA damage or result in DNA synthesis
that is partially defective.
Suppression of erc11 by activation of a partially erc11-independent pathway and suppression by bypass of a checkpoint
arrest are not mutually exclusive hypotheses. CLN1 and CLN2
may have multiple effects on the regulation of DNA synthesis.
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